Scientific Research News
Stay updated on research with press releases highlighting industry news, trends, and innovations driving scientific studies and academic research. Explore opportunities in research methodologies, peer-reviewed publications, and collaborative projects.
Jun 19, 2026 at 12:16 PM
101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease
TEL AVIV, Israel & ENGLEWOOD, N.J.--(BUSINESS WIRE)--101 Therapeutics releases evidence package for 101-PGC-005, seeking independent review for therapeutic use in Bundibugyo Ebola crisis....
Jun 19, 2026 at 11:45 AM
New Critique by Haypp Group Warns Seizure Claims About Nicotine Pouches Overstate Animal Study Findings
STOCKHOLM--(BUSINESS WIRE)--Giving mice a chemically induced epileptic condition and then adding nicotine does not prove that nicotine causes or worsens seizures, according to Haypp Group's recently published criticism of a laboratory study on nicotine pouches. The animal experiment used kainic acid, a well-known compound that is deliberately used to trigger seizures in mice. Before seizures were induced, researchers exposed them to nicotine pouches or cannabidiol (CBD), reporting changes in se...
Jun 19, 2026 at 3:00 AM
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
ESPOO, Finland & MUNICH--(BUSINESS WIRE)--IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). Ciesla, an experienced deep...
Jun 18, 2026 at 9:00 PM
Astrogen Inc. Receives 18th Folia Award for Outstanding Clinical Research in Autism Spectrum Disorder
YOKOHAMA, Japan--(BUSINESS WIRE)--Astrogen, a South Korean biotech company, wins the 18th Folia Award for its autism clinical research, accelerating its expansion into global markets....
Jun 18, 2026 at 1:23 PM
More Than 100 Scientific Papers Leveraged the Dante Labs Technology for Research on Transcriptomics, CRISPR Gene Editing, Ancient DNA samples, Rare Diseases and Oncology
NEW YORK--(BUSINESS WIRE)--Dante Labs enabled more than 100 global scientific studies on rare diseases, transcriptomics, CRISPR gene editing ancient DNA samples and oncology. Dante Labs also published its own papers on peer reviewed journals, including Gene and Nature Communications. Scientists and academic researchers from the US, Italy, Pakistan, Malta and more European countries keep choosing Dante Labs to sequence samples for important studies. Topics include rare diseases, phasing, oncolog...
Jun 18, 2026 at 11:30 AM
Craig Hospital Joins SCI Ventures as Alliance Partner to Accelerate Innovation in Spinal Cord Injury
DENVER--(BUSINESS WIRE)--Craig Hospital, a nationally recognized neurorehabilitation and research hospital specialized in the care of individuals who have sustained spinal cord and brain injuries, announced today it is joining SCI Ventures as an Alliance Partner, reinforcing a shared commitment to bring new therapies to persons living with paralysis. Through the partnership, Craig Hospital will invest in SCI Ventures, join the fund’s board of directors, and contribute clinical expertise and dir...
Jun 18, 2026 at 11:24 AM
Kovina Therapeutics Announces Publication in PNAS Validating HPV E6 Targeted Therapeutic Approach
INDIANAPOLIS--(BUSINESS WIRE)--Kovina Therapeutics Inc. today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of research validating its HPV E6 targeted therapeutic approach. The publication, “Covalent Inhibitors of Human Papillomavirus Type 16 E6 Protein Restore p53 Function and Suppress Growth of HPV-Driven Tumors in vivo,” reports that small molecules developed through Kovina’s HPV E6 program restore p53 tumor suppressor activity, induce apoptosis and sene...
Jun 18, 2026 at 10:46 AM
According to THE SAGE GROUP, the 2025 U.S. Prevalence of Peripheral Artery Disease (PAD) Exceeded 22 Million
BEAUFORT, S.C.--(BUSINESS WIRE)--Since 1995, the number of U.S. citizens with PAD has approximately doubled from 11 million to over 22 million. PAD is extremely costly with a current economic burden of $352-$694 billion, accounting for 7%-13% of National Health Expenditures.“Although PAD prevalence exceeds that of heart disease and stroke, compared to these other cardiovascular diseases, PAD remains underappreciated. PAD is a significant source of morbidity and mortality, as well as a major caus...
Jun 18, 2026 at 10:37 AM
Celebrating Excellence: Life Sciences BC Announces 2026 Award Winners
VANCOUVER, British Columbia--(BUSINESS WIRE)--Celebrating Excellence: Life Sciences BC Announces 2026 Award Winners...
Jun 18, 2026 at 10:19 AM
U.S. Army Awards Rune Technologies with $99M Army Contract for AI-Powered Predictive Logistics Platform
ARLINGTON, Va.--(BUSINESS WIRE)--Rune Technologies, which builds AI-enabled predictive software for military logistics in contested environments, today announced a five-year, $99 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the U.S. Army. The contract establishes an enterprise acquisition vehicle that enables U.S. Army organizations, other Department of War components, and joint force partners, to rapidly procure Rune's TyrOS platform and associated services through str...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.